[
Aumüller, G. (1979). Prostate Gland and Seminal Vesicles. Springer-Verlag, Berlin-Heidelberg. 380 pp.10.1007/978-3-642-67192-0
]Search in Google Scholar
[
Azmi, A. S., Bao, B., Sarkar, F. H. (2013). Exosomes in cancer development, metastasis, and drug resistance: A comprehensive review. Cancer Metastasis Rev., 32 (3–4), 623–642.10.1007/s10555-013-9441-9384398823709120
]Search in Google Scholar
[
Bishayee, K., Khuda-Bukhsh, A. R. (2013). 5-lipoxygenase antagonist therapy: A new approach towards targeted cancer chemotherapy. Acta Biochim. Biophys. Sin. (Shanghai), 45 (9), 709–719.10.1093/abbs/gmt06423752617
]Search in Google Scholar
[
Brajtbord, J. S., Leapman, M. S., Cooperberg, M. R. (2017). The CAPRA score at 10 years: Contemporary perspectives and analysis of supporting studies. Eur. Urol., 71 (5), 705–709.10.1016/j.eururo.2016.08.06527616723
]Search in Google Scholar
[
Catalona, W. J., Partin, A. W., Sanda, M. G., Wei, J. T., Klee, G. G., Bangma, C. H., Slawin, K. M., Marks, L. S., Loeb, S., Broyles, D. L., et al. (2011). A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range. J. Urol., 185 (5),1650–1655.
]Search in Google Scholar
[
D’Amico, A. V., Whittington, R., Malkowicz, S. B. (2000). Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer. J. Clin. Oncol., 18 (6), 1164–1172.10.1200/JCO.2000.18.6.116410715284
]Search in Google Scholar
[
Del Re, M., Biasco, E., Crucitta, S., Derosa, L., Rofi, E., Orlandini, C., Miccoli, M., Galli, L., Falcone, A., Jenster, G. W. (2017). The detection of androgen receptor splice variant 7 in plasma derived exosomal RNA strongly predicts resistance to hormonal therapy in metastatic prostate cancer patients. Eur. Urol., 71, 680–687.10.1016/j.eururo.2016.08.01227733296
]Search in Google Scholar
[
Filella, X., Fernández-Galan, E., Fernández Bonifacio, R., Foj L. (2018). Emerging biomarkers in the diagnosis of prostate cancer. Pharmgenomics Pers. Med., 11, 83–94.10.2147/PGPM.S136026596164329844697
]Search in Google Scholar
[
Ghosh, J., Myers, C. E. (1998). Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc. Natl. Acad. Sci. U.S.A., 95 (22), 13182–13187.10.1073/pnas.95.22.13182237529789062
]Search in Google Scholar
[
Goldstein, A. S., Huang, J., Guo, C., Garraway, I. P., Witte, O. N. (2010). Identification of a cell of origin for human prostate cancer. Science. 329 (5991), 568–571.
]Search in Google Scholar
[
Greene, E. R., Huang, S., Serhan, C. N., Panigrahy, D. (2011). Regulation of inflammation in cancer by eicosanoids. Prostaglandins Other Lipid Mediat., 96 (1–4), 27–36.10.1016/j.prostaglandins.2011.08.004405134421864702
]Search in Google Scholar
[
Helgesen, F., Holmberg, L., Johansson, J. E. (1996). Trends in prostate cancer survival in Sweden, 1960 through 1988, evidence of increasing diagnosis of non-lethal tumours. J. Natl. Cancer Inst., 88 (17), 1216–1221.10.1093/jnci/88.17.12168780631
]Search in Google Scholar
[
Ingrosso, G., Detti, B., Scartoni, D., Lancia, A., Giacomelli, I., Baki, M., Carta, G., Livi, L., Santoni, R. (2018). Current therapeutic options in meta-static castration-resistant prostate cancer. Semin. Oncol., 45, 303–315.10.1053/j.seminoncol.2018.10.00130446166
]Search in Google Scholar
[
Jahn, J. L, Giovannucci, E. L., Stampfer, M. J. (2015). The high prevalence of undiagnosed prostate cancer at autopsy: Implications for epidemiology and treatment of prostate cancer in the prostate-specific antigen-era. Int. J. Cancer, 137 (12), 2795–2802.10.1002/ijc.29408448597725557753
]Search in Google Scholar
[
Kharaziha, P., Chioureas, D., Rutishauser, D., Baltatzis, G., Lennartsson, L., Fonseca, P., Azimi, A., Hultenby, K., Zubarev, R., Ullen, A. (2015). Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. Oncotarget, 6, 21740–21754.10.18632/oncotarget.3226467330025844599
]Search in Google Scholar
[
Kim, S. J., Kim, S. I. (2011). Current treatment strategies for castration-resistant prostate cancer. Korean J. Urol., 52, 157–165.10.4111/kju.2011.52.3.157306512621461278
]Search in Google Scholar
[
Kretschmer, A., Tilki, D. (2017). Biomarkers in prostate cancer: Current clinical utility and future perspectives. Crit. Rev. Oncol. Hematol., 120, 180–193.10.1016/j.critrevonc.2017.11.00729198331
]Search in Google Scholar
[
Leav, I., Plescia, J., Goel, H. L., Li, J., Jiang, Z., Cohen, R. J., Languino, L. R., Altieri, D. C. (2010). Cytoprotective mitochondrial chaperone TRAP-1 as a novel molecular target in localized and metastatic prostate cancer. Amer. J. Pathol., 176 (1), 393–401.10.2353/ajpath.2010.090521279789919948822
]Search in Google Scholar
[
LSM.LV (2019). https://www.lsm.lv/raksts/zinas/latvija/visizplatitakais-veza-veids-viriesiem-prostatas-laundabigais-audzejs.a335221/ (accessed 10.08.2021) (in Latvian).
]Search in Google Scholar
[
Lu-Yao, G., Albertsen, P. C., Stamford, J. L. (2002). Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut. BMJ, 325 (7367), 740.10.1136/bmj.325.7367.74012837312364300
]Search in Google Scholar
[
Moore, K., Dalley, A. (1999). Clinically Oriented Anatomy. Lippincott Williams & Wilkins, Baltimore, Maryland. 1163 pp.
]Search in Google Scholar
[
Mottet, N., Cornford, P., van den Bergh, R. C. N., De Santis, M., Fanti, S., Gillessen, S., Grummet, J., Henry, A. M., Lam, T. B., Mason, M. D., van der Kwast, T. H., van der Poel, H. G., Rouviere, O., Schoots, I. G., Tilki, D., Wiegel, T. (2020). Oncology Guidelines, Prostate Cancer. https://uroweb.org/guideline/prostate-cancer/ (accessed 10.08.2021).
]Search in Google Scholar
[
Narizhneva, N. V., Tararova, N. D., Ryabokon, P., Shyshynova, I., Prokvolit, A., Komarov, P. G., Purmal, A. A., Gudkov, A. V., Gurova, K. V. (2009). Small molecule screening reveals a transcription-independent pro-survival function of androgen receptor in castration-resistant prostate cancer. Cell Cycle, 8 (24), 4155–4167.10.4161/cc.8.24.10316289689519946220
]Search in Google Scholar
[
Reedy, G. M., Cance, W. G., Kim, K., Lacasse, L., Phillips, T., Reicin, K. (2020). About Prostate Cancer. American Cancer Society.
]Search in Google Scholar
[
Rosenberg, J. E. (2005). Scientists discover anti-cancer mechanism that arrests early prostate cancer. Science Daily, 4 August. https://www.sciencedaily.com/releases/2005/08/050804074959.htm (accessed 10.08.2021).
]Search in Google Scholar
[
Schmelz, H. U., Sparwasser C., Weidner, W. (2006). Facharztwissen Urologie, Differenzierte Diagnostik und Therapie. Springer Medizin Verlag, Heidelberg. 736 S.
]Search in Google Scholar
[
Senapati, S., Rachagani, S., Chaudhary, K., Johansson, S. L., Singh, R. K., Batra, S. K. (2010). Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK–RhoA signaling pathway. Oncogene. 29 (9), 1293–1302.10.1038/onc.2009.420289681719946339
]Search in Google Scholar
[
Siegel, R. L., Miller, K. D., Jemal, A. (2019). Cancer statistics, 2019. CA Cancer J. Clin. 69, 7–34.10.3322/caac.2155130620402
]Search in Google Scholar
[
Soekmadji, C., Russell, P. J., Nelson, C. C. (2013). Exosomes in prostate cancer: Putting together the pieces of a puzzle. Cancers (Basel), 5 (4), 1522–1544.10.3390/cancers5041522
]Search in Google Scholar
[
Stieve, H. (1930). Männliche Genitalorgane. In: Handbuch der mikroskopischen Anatomie des Menschen. Vol. VII Part 2. Springer, Berlin.
]Search in Google Scholar
[
Strom, P., Kartasalo, K., Olsson, H., Solorzano, L., Delahunt, B., Berney, D. M., Bostwick, D. G., Evans, A. J., Grignon, D. J., Humphrey, P. A. et al. (2020). Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study. Lancet Oncol., 21 (2), 222–232.10.1016/S1470-2045(19)30738-7
]Search in Google Scholar
[
Tarhan, F., Orcun, A., Kucukercan, I., Camursoy, N., Kuyumcuoglu, U. (2005). Effect of prostatic massage on serum complexed prostate-specific antigen levels. Urology, 66,1234–1238.10.1016/j.urology.2005.06.07716360449
]Search in Google Scholar
[
Thompson, I. M. (2006). PSA: A biomarker for disease. A biomarker for clinical trials. How useful is it? J. Nutr., 136, 2704S.
]Search in Google Scholar
[
van der Pol, E., Böing, A. N., Harrison, P., Sturk, A., Nieuwland, R. (2012). Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol. Rev., 64 (3), 676–705.10.1124/pr.112.00598322722893
]Search in Google Scholar
[
Van Leenders, G. J. L. H., van der Kwast, T. H., Grignon, D. J., Evans, A. J., Kristiansen, G., Kweldam, C. F., Litjens, G., McKenney, J. K., Melamed, J., Mottet, N., et al. (2020). The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma. Amer. J. Surg. Pathol., 44 (8), e87–e99.10.1097/PAS.0000000000001497738253332459716
]Search in Google Scholar
[
Watanabe, S. I., Miyata, Y., Kanda, S., Iwata, T., Hayashi, T., Kanetake, H., Sakai, H. (2009). Expression of X-linked inhibitor of apoptosis protein in human prostate cancer specimens with and without neo-adjuvant hormonal therapy. J. Cancer Res. Clin. Oncol., 136 (5), 787–793.
]Search in Google Scholar
[
Yao, V., Berkman, C. E., Choi, J. K., O’Keefe, D. S., Bacich, D. J. (2010). Expression of prostate-specific membrane antigen (PSMA), increases cell folate uptake and proliferation and suggests a novel role for PSMA in the uptake of the non-polyglutamated folate, folic acid. Prostate, 70 (3), 305–316.10.1002/pros.2106519830782
]Search in Google Scholar
[
Zha, J., Huang, Y. F. (2009). TGF-beta/Smad in prostate cancer: An update. Zhonghua Nan Ke Xue (in Chinese), 15 (9), 840–843.
]Search in Google Scholar
